10月29日,默沙东盘前涨超3%,第三季度全球营收180.85亿美元,同比增长5%;净利润50.65亿美元,同比下降12%;调整后每股收益2.49美元,上年同期为2.58美元。核心产品Keytruda及Keytruda Qlex销售额86.01亿美元,同比增长6%;肺动脉高压药物Winrevair销售额6.94亿美元,同比增长93%。公司上调全年营收指引至668亿至673亿美元,并将全年调整后每股收益指引上调至2.77至2.82美元。
老虎资讯综合10-29
10月29日,默沙东盘前涨超3%,第三季度全球营收180.85亿美元,同比增长5%;净利润50.65亿美元,同比下降12%;调整后每股收益2.49美元,上年同期为2.58美元。核心产品Keytruda及Keytruda Qlex销售额86.01亿美元,同比增长6%;肺动脉高压药物Winrevair销售额6.94亿美元,同比增长93%。公司上调全年营收指引至668亿至673亿美元,并将全年调整后每股收益指引上调至2.77至2.82美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
